Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 72971 SAN FRANCISCO, CA
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$316,215
+$315,554 QoQ
Shares Held
67,712
+19357.5% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 89 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. XFOR ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in XFOR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $316,215 67,712
2025-06-30 $661 348
2025-03-31 $19,242 81,536
2024-12-31 $57,632 78,518
2024-09-30 $34,624 51,755
2024-06-30 $31,203 53,799
2024-03-31 $56,939 40,964
2023-12-31 $29,385 35,024
2023-09-30 $30,114 27,628
2023-06-30 $95,156 49,050
2023-03-31 $655 753
2022-12-31 $424 427
2022-09-30 $990 579
2022-06-30 $163 169
2022-03-31 $248 142
2021-12-31 $286 125
2021-09-30 $661 125
2021-06-30 $857 132
2021-03-31 $48,034 5,579
2020-12-31 $174,611 27,156
2020-09-30 $89,661 13,244
2020-06-30 $162,344 17,419
2020-03-31 $241,357 24,136